Anti-Cas9
Anti-FKBP12 Anti-VSV-G (A) Western blot analysis of EVs containing FRB-SpCas9 and no FKBP12 interaction partner, VSV-G-FKBP12, FKBP12-EGFP-A, or FKBP12-Gag HIV in the presence or absence of AP21967, used in Figure 1 . VSV-G protein amount was also examined as a loading control of EVs. Results are representative of two independent western blot images from two independent experiments. (B) Cleavage activity of FRB-SpCas9 fusion constructs. The mutation frequency of WT SpCas9, FRB N-terminal SpCas9 (*SpCas9), FRB C-terminal SpCas9 (SpCas9*), and FRB N-and C-terminal SpCas9 (*SpCas9*) activity were assessed in HEK293T cells transfected with the fusion constructs and DMD1-sgRNA. gDNA was extracted 3 days after transfection and analyzed by T7E1 assay. (C) Relative expression of SpCas9 protein 3 days post transfection was determined by western blot quantification normalized by actin (ACTB) protein. Results are representative of two independent western blot images from a single experiment. (D) Western blot analysis of NanoMEDIC generated in the presence or absence of AP21967 with *SpCas9, SpCas9*, or *SpCas9*. Relative amount SpCas9 was determined by dividing the density of the SpCas9 band by that of the VSV-G band. Results are representative of two independent western blot images from a single experiment. (A) AP21967 and sgRNA expression synergistically recruit FRB-SpCas9 into NanoMEDIC. Western blot of FRB-SpCas9 protein contained in the NanoMEDIC particles. Western results are representative of two western blots from two independent NanoMEDIC preps. (B) All-in-one concentrated NanoMEDIC particles containing RGR-DMD1 or no sgRNA were inoculated onto HEK293T EGxxFP reporter cells at the indicated volumes. The results show SSA-GFP+ expression measured by flow cytometry analysis 3 days after inoculation. Mean ± S.D. from technical triplicates. (C) A comparison of proteins contained in exosomes released from HEK293T cells compared with NanoMEDIC produced with AP21967 and RGR-DMD1. The scatter plot shows NanoMEDIC proteins in green (derived from components of the NanoMEDIC VSV-G envelope, SpCas9 protein, and Gag HIV , and Tat), common exosome related proteins in red (CD63 and CD81), and other enriched proteins associated with Gag in yellow (IGF2BP1 and PPIA). (D) Commercially available Guide-It Clontech gesicles and NanoMEDIC were produced side-by-side at the same scale and inoculated onto HEK293T EGxxFP reporter cells. Three days after inoculation, cleavage activity was analyzed for SSA-GFP+ expression by flow cytometry. Flow cytometry results of HEK293T EGxxFP cells inoculated with VSV-G only EVs, Guide-It Clontech gesicles, or NanoMEDIC are depicted in the bar graph. ****, P < 0.0001 by unpaired two-tailed t-test. Mean ± S.D. from technical triplicates. Example of flow cytometry analysis for HEK293T EGxxFP reporter cells. First, live cells were gated for FSC-A and SSC-A to remove cell debris. Then, GRP+ gate was set based on negative controls.
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